Resources

DecisionDx Squamous Cell Carcinoma

Helpful references to learn more about DecisionDx-SCC

Hear from experts and patients alike and learn more about improving risk assessment in DecisionDx-SCC patients.

Individualized risk information: An introduction to DecisionDx-SCC

  • Tumor biology matters

    DecisionDx-SCC is a genomic test that looks at the tumor biology of  squamous cell carcinoma (SCC) of the skin to better understand the risk of cancer spreading to other parts of body

Individualized risk information: An introduction to DecisionDx-SCC

  • Dr. David Cotter, MD, PhD, Dermatologist Las Vegas Dermatology shares the value of the DecisionDx-SCC test for his patients

    Learn more about what Dermatologist Dr. David Cotter finds most valuable about utilizing DecisionDx-SCC to personalize care for his high-risk SCC patients.

Expert opinions on the treatment and management of squamous cell carcinoma.

  • Brent Moody, MD, FACP, FAAD, Dermatologist and Mohs Surgeon, Heritage Medical Associates              

    Learn how Mohs Surgeon Dr. Brent Moody utilizes DecisionDx-SCC for his high-risk SCC patients to clarify their cancer management and treatment plans.

  • David Cotter, MD, PhD, Dermatologist, Las Vegas Dermatology                                                                          

    Learn about what Dermatologist Dr. David Cotter finds most valuable about utilizing DecisionDx-SCC to personalize care for his high-risk SCC patients.

  • Philip Andrews, NP, Dermatology, Chattanooga Skin and Cancer Clinic

    Learn how Dermatology Nurse Practioner Philip Andrews utilizes DecisionDx-SCC to improve follow-up, referral and treatment recommendations for his high-risk SCC patients.

Explore on-demand content

  • AHNS DecisionDx–SCC Webinar: Identifying the Risk of Metastasis in cSCC and cSCC-HN Patients

    Jason Newman, MD, FACS, Professor of Otorhinolaryngology – Head and Neck Surgery, University of Pennsylvania

     

    CME/CE: N/A

    Access Now

  • Maui Derm DecisionDx-SCC Product Theater: Identifying the Risk of Metastasis in cSCC Patients with One or More Risk Factors.

    Faculty: Brent Moody, MD, FACP, FAAD, Fellow, American College of Mohs Surgery

     

    CME/CE: N/A

    Access Now
  • DecisionDx Squamous Cell Carcinoma

    Enhanced Metastatic Risk Assessment in Cutaneous Squamous Cell Carcinoma with the 40-Gene Expression Profile Test: An Interview with the Lead Author of DecisionDx-SCC’s Validation Study

    Sherrif F. Ibrahim, MD, PhD, Assistant Professor, Department of Dermatology, University of Rochester Medical Center

     

    CME/CE: N/A

    Access Now

  • The DecisionDx-SCC test is a game changer”

    Phil Andrews, NP/PA